Kendall Law Group, a national securities firm, is investigating Odyssey HealthCare, Inc. (NASDAQ:ODSY) for shareholders in connection with the proposed sale of Odyssey HealthCare to Gentiva Health Services, Inc. The firm’s investigation seeks to determine whether Odyssey HealthCare and its Board breached their fiduciary duties by entering into the agreement without properly shopping for a deal that would provide better value for shareholders. If you are an Odyssey HealthCare shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at skendall@kendalllawgroup.com.

The companies announced on May 24, 2010 that they had entered into an agreement for Odyssey to be acquired by Gentiva for approximately $1 billion. According to the agreement, Odyssey will be acquired in an all cash transaction for a price of $27 per share of common stock. Odyssey has received mostly positive analyst opinions since 2005, with a notable upgrade to “buy” from Zacks Investment Research due to “soaring estimates” after the report of a “fifth consecutive earnings surprise.” The firm’s investigation concerns the process the Board of Odyssey HealthCare undertook in entering into the merger agreement and to determine if the agreement properly values the stock for shareholders.

Kendall Law Group was founded by a former federal judge, includes a former United States Attorney, prosecutors and securities lawyers who are experienced in complex securities litigation. The firm has been counsel in numerous merger and acquisition cases nationwide, including some of the largest transactions in the United States.

Odyssey Healthcare (MM) (NASDAQ:ODSY)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Odyssey Healthcare (MM).
Odyssey Healthcare (MM) (NASDAQ:ODSY)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Odyssey Healthcare (MM).